Policy and Legislation
Over 18% of consumers signing up for a plan are new to the marketplace, including some who formerly had Medicaid coverage.
Secretary Becerra asks that stakeholders alert HHS of any issues that arise regarding COVID-19 therapeutics access.
The approval, the agency says, allows New York to make large investments in wide-ranging Medicaid initiatives.
Members of the HELP Committee are criticizing drugmakers for charging more for inhalers in the U.S. than in other countries.
Hospitalizations for COVID-19 have increased 20% since mid-November, according to the CDC.
The disincentive structure proposed is excessive and threatens the financial viability of economically fragile hospitals, AHA says.
Various agencies are regulating different aspects of AI, says Bryant Godfrey, partner at Foley Hoag.
Rebates bring down prices by as much as half.
AI can make healthcare more human by alleviating much of the burden, says Jay Rughani, investment partner at a16z, who, with colleagues recently released, "AI: The Teammate Clinicians Need."
The Trusted Exchange Framework and Common Agreement is now live, but the challenge is FHIR in TEFCA, says Don Rucker, chief strategy officer for 1upHealth and former national coordinator for Health IT at HHS.